Neisseria gonorrhoeae contaminations are the second most normal bacterial explicitly communicated diseases (STI) in our general vicinity. Protection from this microorganism is right now thought to be a worldwide danger by the World Health Organization (WHO). Current Spanish rules suggest a double treatment with expanded range cephalosporines, (for example, cefotaxime, ceftriaxone, cefuroxime or cefixime) and azithromycin (AZT). Double treatment has indicated collaboration in-vitro and in-vivo and is viable against Chlamydia trachomatis. In pharyngeal contaminations cephalosporins have demonstrated to be less compelling than quinolones; consequently, UK rule suggest ciprofloxacin (CIP) in pharyngeal disease if the segregate is known to be quinolone powerless. Then again, European and German rules suggest quinolones as an elective treatment in pharyngeal diseases if the segregated strain is helpless to these mixes and there are signs against utilizing ceftriaxone.